HIV coreceptors, cell tropism and inhibition by chemokine receptor ligands

References

• Bagasra, O., Lavi, E., Bobroski, L., Khalili, K., Pestaner, J. P., Tawadros, R. and Pomerantz, R. J., 1996, Cellular reservoirs of HIV-1 in the central nervous system of infected individuals: identification by the combination of in situ polymerase chain reaction and immunohistochemistry. AIDS, 10, 573–585.
   PubMed Web of Science ®Google Scholar
• Berger, E. A., 1997, HIV entry and tropism: the chemokine receptor connection. AIDS, 11, S3–S16.
   PubMed Web of Science ®Google Scholar
• Berger, E. A., Doms, R. W., Fenyo, E.-M., Korber, B. T. M., Littman, D. R., Moore, J. P., Sattentau, Q. J., Schuitemaker, H., Sodroski, J. and Weiss, R. A., 1998, A new classification for HIV-1. Nature, 391, 240.
   PubMed Web of Science ®Google Scholar
• Bieniasz, P. D., Fridell, R. A., Aramori, I., Ferguson, S. S., Caron, M. G. and Cullen, B. R., 1997, HIV-1-induced cell fusion is mediated by multiple regions within both the viral envelope and the CCR-5 co-receptor. Embo Journal, 16, 2599–2609.
   PubMed Web of Science ®Google Scholar
• Clapham, P. R., 1991, Human immunodeficiency virus infection of non-haematopoietic cells. The role of CD4-independent infection. Reviews in Medical Virology, 1, 51–58.
   Google Scholar
• Clapham, P. R., 1997, HIV and chemokines: ligands sharing cell-surface receptors. Trends in Cell Biology, 7, 264–268.
   PubMed Web of Science ®Google Scholar
• Clapham, P. R., McKnight, A., Talbot, S. and Wilkinson, D., 1996, HIV entry into cells by CD4-independent mechanisms. In HIV infection in CD4- cells, J. Fantini and J.-M. Sabatier, Eds (ESCOM science publishers B. V., The Netherlands), Vol. 5, pp. 83–92.
   Google Scholar
• Clapham, P. R., McKnight, A. and Weiss, R. A., 1992, Human immunodeficiency virus type 2 infection and fusion of CD4-negative human cell lines: induction and enhancement by soluble CD4. Journal of Virology, 66, 3531–3537.
   PubMed Web of Science ®Google Scholar
• Dean, M., Carrington, M., Winkler, C., Huttley, G. A., Smith, M. W., Allikmets, R., Goedert, J. J., Buchbinder, S. P., Vittinghoff, E., Gomperts, E., Donfield, S., Vlahov, D., Kaslow, R., Saah, A., Rinaldo, C., Detels, R. and O’Brien, S.J., 1996, Genetic restriction of HIV-1 infection and progression to AIDS by a deletion allele of the CKR5 structural gene. Hemophilia Growth and Development Study, Multicenter AIDS Cohort Study, Multicenter Hemophilia Cohort Study, San Francisco City Cohort, ALIVE Study. Science, 273, 1856-1862.
   PubMed Web of Science ®Google Scholar
• Delezay, O., Koch, N., Yahi, N., Hammache, D., Tourres, C., Tamalet, C. and Fantini, J., 1997, Co-expression of CXCR4/fusin and galactosylceramide in the human intestinal epithelial cell line HT-29. AIDS, 11, 1311–1318.
   PubMed Web of Science ®Google Scholar
• Donzella, G. A., Schols, D., Lin, S. W., Este, J. A., Nagashima, K. A., Maddon, P. J., Allaway, G. P., Sakmar, T. P., Henson, G., De Clercq, E. and Moore, J. P., 1998, AMD3100, a small molecule inhibitor of HIV-1 entry via the CXCR4 co-receptor. Nature Medicine 4, 72–77.
   PubMed Web of Science ®Google Scholar
• Doranz, B. J., Grovit Ferbas, K., Sharron, M. P., Mao, S. H., Goetz, M. B., Daar, E. S., Doms, R. W. and O’Brien, W. A., 1997, A small-molecule inhibitor directed against the chemokine receptor CXCR4 prevents its use as an HIV-1 coreceptor. Journal Experimental Medicine, 186, 1395–1400.
   PubMed Web of Science ®Google Scholar
• Dragic, T., Trkola, A., Lin, S. W., Nagashima, K. A., Kajumo, F., Zhao, L., Olson, W. C., Wu, L., Mackay, C. R., Allaway, G. P., Sakmar, T. P., Moore, J. P. and Maddon, P. J., 1998, Amino-terminal substitutions in the CCR5 coreceptor impair gp120 binding and human immunodeficiency virus type 1 entry. Journal of Virology, 72, 279–285.
   PubMed Web of Science ®Google Scholar
• Edinger, A. L., Amedee, A., Miller, K., Doranz, B. J., Endres, M., Sharron, M., Samson, M., Lu, Z. H., Clements, J. E., Murphey Corb, M., Peiper, S. C., Parmentier, M., Broder, C. C. and Doms, R. W., 1997, Differential utilization of CCR5 by macrophage and T cell tropic simian immunodeficiency virus strains. Proceedings of the National Academy of Sciences USA, 94, 4005–4010.
   PubMed Web of Science ®Google Scholar
• Emerman, M., Bukrinsky, M. and Stevenson, M., 1994, HIV-1 infection of non-dividing cells. Nature, 369, 108.
   Web of Science ®Google Scholar
• Endres, M. J., Clapham, P. R., Marsh, M., Ahuja, M., Turner, J. D., McKnight, A., Thomas, J. F., Stoebenau Haggarty, B., Choe, S., Vance, P. J., Wells, T. N., Power, C. A., Sutterwala, S. S., Doms, R. W., Landau, N. R. and Hoxie, J. A., 1996, CD4-independent infection by HIV-2 is mediated by fusin/CXCR4. Cell, 87, 745-756.
   Google Scholar
• Fantini, J., Cook, D. G., Nathanson, N., Spitalnik, S. L. and Gonzalez Scarano, F., 1993, Infection of colonic epithelial cell lines by type 1 human immunodeficiency virus is associated with cell surface expression of galactosylceramide, a potential alternative gp120 receptor. Proceedings of the National Academy of Sciences USA, 90, 2700–2704.
   PubMed Web of Science ®Google Scholar
• Fear, W. R., Kesson, A. M., Naif, H., G.W., L. and Cunningham, A. L., 1998, Differential tropism and chemokine receptor expression of human immunodeficiency virus type 1 in neonatal monocytes, monocyte-derived macrophages, and placental macrophages. Journal of Virology, 72, 1334-1344.
   Google Scholar
• Guillon, C., van der Ende, M. E., Boers, P. H., Gruters, R. A., Schutten, M. and Osterhaus, A. D., 1998, Coreceptor usage of human immunodeficiency virus type 2 primary isolates and biological clones is broad and does not correlate with their syncytium-inducing capacities. Journal of Virology, 72, 6260–6263.
   PubMed Web of Science ®Google Scholar
• Harouse, J. M., Bhat, S., Spitalnik, S. L., Laughlin, M., Stefano, K., Silberberg, D. H. and Gonzalez Scarano, F., 1991, Inhibition of entry of HIV-1 in neural cell lines by antibodies against galactosyl ceramide. Science, 253, 320–323.
   PubMed Web of Science ®Google Scholar
• Huang, Y., Paxton, W. A., Wolinsky, S. M., Neumann, A. U., Zhang, L., He, T., Kang, S., Ceradini, D., Jin, Z., Yazdanbakhsh, K., Kunstman, K., Erickson, D., Dragon, E., Landau, N. R., Phair, J., Ho, D. D. and Koup, R. A., 1996, The role of a mutant CCR5 allele in HIV-1 transmission and disease progression. Nature Medicine, 2, 1240–1243.
   PubMed Web of Science ®Google Scholar
• Hwang, S. S., Boyle, T. J., Lyerly, H. K. and Cullen, B. R., 1991, Identification of the envelope V3 loop as the primary determinant of cell tropism in HIV-1. Science, 253, 71–74.
   PubMed Web of Science ®Google Scholar
• Karita, E., Nkengasong, J. N., Willems, B., Vanham, G., Fransen, K., Heyndrickx, L., Janssens, W., Piot, P. and van der Groen, G., 1997, Macrophage-tropism of HIV-1 isolates of different genetic subtypes. AIDS, 11, 1303–1304.
   PubMed Web of Science ®Google Scholar
• Kledal, T. N., Rosenkilde, M. M., Coulin, F., Simmons, G., Johnsen, A. H., Alouani, S., Power, C. A., Luttichau, H. R., Gerstoft, J., Clapham, P. R., Clark Lewis, I., Wells, T. N. C. and Schwartz, T. W., 1997, A broad-spectrum chemokine antagonist encoded by Kaposi’s sarcoma-associated herpesvirus. Science 277, 1656–1659.
   PubMed Web of Science ®Google Scholar
• Kwong, P. D., Wyatt, R., Robinson, J., Sweet, R. W., Sodroski, J. and Hendrickson, W. A., 1998, Structure of an HIV gp120 envelope glycoprotein in complex with the CD4 receptor and a neutralizing human antibody. Nature, 393, 648–659.
   PubMed Web of Science ®Google Scholar
• Liu, R., Paxton, W. A., Choe, S., Ceradini, D., Martin, S. R., Horuk, R., MacDonald, M. E., Stuhlmann, H., Koup, R. A. and Landau, N. R., 1996, Homozygous defect in HIV-1 coreceptor accounts for resistance of some multiply-exposed individuals to HIV-1 infection. Cell, 86, 367–377.
   PubMed Web of Science ®Google Scholar
• Mack, M., Luckow, B., Nelson, P. J., Cihak, J., Simmons, G., Clapham, P. R., Signoret, N., Marsh, M., Stangassinger, M., Borlat, F., Wells, T. N., Schlondorff, D. and Proudfoot, A. E., 1998, Aminooxypentane-RANTES induces CCR5 internalization but inhibits recycling: a novel inhibitory mechanism of HIV infectivity. Journal of Experimental Medicine, 187, 1215–1224.
   PubMed Web of Science ®Google Scholar
• Martin, K. A., Wyatt, R., Farzan, M., Choe, H., Marcon, L., Desjardins, E., Robinson, J., Sodroski, J., Gerard, C. and Gerard, N. P., 1997, CD4-independent binding of SIV gp120 to rhesus CCR5. Science, 278, 1470–1473.
   PubMed Web of Science ®Google Scholar
• McKnight, A., Clapham, P. R. and Weiss, R. A., 1994, HIV-2 and SIV infection of nonprimate cell lines expressing human CD4: restrictions to replication at distinct stages. Virology, 201, 8–18.
   PubMed Web of Science ®Google Scholar
• McKnight, A., Dittmar, M. T., Moniz Periera, J., Ariyoshi, K., Reeves, J. D., Hibbitts, S., Whitby, D., Aarons, E., Proudfoot, A. E., Whittle, H. and Clapham, P. R., 1998, A broad range of chemokine receptors are used by primary isolates of human immunodefi-ciency virus type 2 as coreceptors with CD4. Journal of Virology, 72, 4065–4071.
   PubMed Web of Science ®Google Scholar
• McKnight, A., Wilkinson, D., Simmons, G., Talbot, S., Picard, L., Ahuja, M., Marsh, M., Hoxie, J. A. and Clapham, P. R., 1997, Inhibition of human immunodeficiency virus fusion by a mono-clonal antibody to a coreceptor (CXCR4) is both cell type and virus strain dependent. Journal of Virology, 71, 1692–1696.
   PubMed Web of Science ®Google Scholar
• Mondor, I., Ugolini, S. and Sattentau, Q. J., 1998, Human immunodeficiency virus type 1 attachment to HeLa CD4 cells is CD4 independent and gp120 dependent and requires cell surface heparans. Journal of Virology 72, 3623–3634.
   PubMed Web of Science ®Google Scholar
• Moore, J. P., Trkola, A. and Dragic, T., 1997, Co-receptors for HIV-1 entry. Current Opinion in Immunology, 9, 551–562.
   PubMed Web of Science ®Google Scholar
• Murakami, T., Nakajima, T., Koyanagi, Y., Tachibana, K., Fujii, N., Tamamura, H., Yoshida, N., Waki, M., Matsumoto, A., Yoshie, O., Kishimoto, T., Yamamoto, N. and Nagasawa, T., 1997, A small molecule CXCR4 inhibitor that blocks T cell line-tropic HIV-1 infection. Journal of Experimental Medicine, 186, 1389–1393.
   PubMed Web of Science ®Google Scholar
• Owen, S. M., Ellenberger, D., Rayfield, M., Wiktor, S., Michel, P., Grieco, M. H., Gao, F., Hahn, B. H. and Lal, R. B., 1998, Genetically divergent strains of human immunodeficiency virus type 2 use multiple coreceptors for viral entry. Journal of Virology, 72, 5425–5432.
   PubMed Web of Science ®Google Scholar
• Picard, L., Simmons, G., Power, C. A., Meyer, A., Weiss, R. A. and Clapham, P. R., 1997, Multiple extracellular domains of CCR-5 contribute to human immunodeficiency virus type 1 entry and fusion. Journal of Virology, 71, 5003–5011.
   PubMed Web of Science ®Google Scholar
• Proudfoot, A. E. I., Wells, T. N. C. and Clapham, P. R., 1998, Chemokine receptors-future therapeutic targets for HIV? Bio-chemical Pharmacology, 57, in press.
   Google Scholar
• Reeves, J. D., McKnight, A., Potempa, S., Simmons, G., Gray, P. W., Power, C. A., Wells, T., Weiss, R. A. and Talbot, S. J., 1997, CD4-independent infection by HIV-2 (ROD/B): use of the 7-transmembrane receptors CXCR-4, CCR-3, and V28 for entry. Virology, 231, 130–134.
   PubMed Web of Science ®Google Scholar
• Saag, M. S., Holodniy, M., Kuritzkes, D. R., WA, O. B., Coombs, R., Poscher, M. E., Jacobsen, D. M., Shaw, G. M., Richman, D. D. and Volberding, P. A., 1996, HIV viral load markers in clinical practice. Nature Medicine, 2, 625–629.
   Google Scholar
• Samson, M., Libert, F., Doranz, B. J., Rucker, J., Liesnard, C., Farber, C. M., Saragosti, S., Lapoumeroulie, C., Cognaux, J., Forceille, C., Muyldermans, G., Verhofstede, C., Burtonboy, G., Georges, M., Imai, T., Rana, S., Yi, Y., Smyth, R. J., Collman, R. G., Doms, R. W., Vassart, G. and Parmentier, M., 1996, Resistance to HIV-1 infection in caucasian individuals bearing mutant alleles of the CCR-5 chemokine receptor gene. Nature, 382, 722–725.
   PubMed Web of Science ®Google Scholar
• Schols, D., Struyf, S., Van Damme, J., Este, J. A., Henson, G. and De Clercq, E., 1997, Inhibition of T-tropic HIV strains by selective antagonization of the chemokine receptor CXCR4. Journal of Experimental Medicine, 186, 1383–1388.
   PubMed Web of Science ®Google Scholar
• Schuitemaker, H., Kootstra, N. A., de Goede, R. E., de Wolf, F., Miedema, F. and Tersmette, M., 1991, Monocytotropic human immunodeficiency virus type 1 (HIV-1) variants detectable in all stages of HIV-1 infection lack T-cell line tropism and syncytium-inducing ability in primary T-cell culture. Journal of Virology, 65, 356–363.
   PubMed Web of Science ®Google Scholar
• Sharer, L. R., Saito, Y., Epstein, L. G. and Blumberg, B. M., 1994, Detection of HIV-1 DNA in pediatric AIDS brain tissue by two-step ISPCR. Advances in Neuroimmunology, 4, 283–285.
   PubMedGoogle Scholar
• Simmons, G., Clapham, P. R., Picard, L., Offord, R. E., Rosenkilde, M. M., Schwartz, T. W., Buser, R., Wells, T. N. C. and Proudfoot, A. E., 1997, Potent inhibition of HIV-1 infectivity in macrophages and lymphocytes by a novel CCR5 antagonist. Science, 276, 276–279.
   PubMed Web of Science ®Google Scholar
• Simmons, G., Reeves, J. D., McKnight, A., Dejucq, N., Hibbitts, S., Power, C. A., Aarons, E., Schols, D., Clercq, E. D., Proudfoot, A. E. I. and Clapham, P. R., 1998, CXCR4 as a Functional Coreceptor for Human Immunodeficiency Virus Type 1 Infection of Primary Macrophages. Journal of Virology, 72, 8453–8457.
   PubMed Web of Science ®Google Scholar
• Simmons, G., Wilkinson, D., Reeves, J. D., Dittmar, M. T., Beddows, S., Weber, J., Carnegie, G., Desselberger, U., Gray, P. W., Weiss, R. A. and Clapham, P. R., 1996, Primary, syncytium-inducing human immunodeficiency virus type 1 isolates are dual-tropic and most can use either Lestr or CCR5 as coreceptors for virus entry. Journal of Virology 70, 8355–8360.
   PubMed Web of Science ®Google Scholar
• Sol, N., Ferchal, F., Braun, J., Pleskoff, O., Treboute, C., Ansart, I. and Alizon, M., 1997, Usage of the coreceptors CCR-5, CCR-3, and CXCR-4 by primary and cell line-adapted human immunode-ficiency virus type 2. Journal of Virology 71, 8237–8244.
   PubMed Web of Science ®Google Scholar
• Trkola, A., Dragic, T., Arthos, J., Binley, J. M., Olson, W. C., Allaway, G. P., Cheng Mayer, C., Robinson, J., Maddon, P. J. and Moore, J. P., 1996, CD4-dependent, antibody-sensitive interactions between HIV-1 and its co-receptor CCR-5. Nature, 384, 184–187.
   PubMed Web of Science ®Google Scholar
• Valentin, A., Albert, J., Fenyo, E. M. and Asjo, B., 1994, Dual tropism for macrophages and lymphocytes is a common feature of primary human immunodeficiency virus type 1 and 2 isolates. Journal of Virology, 68, 6684–6689.
   PubMed Web of Science ®Google Scholar
• Willett, B. J., Picard, L., Hosie, M. J., Turner, J. D., Adema, K. and Clapham, P. R., 1997, Shared usage of the chemokine receptor CXCR4 by the feline and human immunodeficiency viruses. Journal of Virology, 71, 6407–6415.
   PubMed Web of Science ®Google Scholar
• Wu, L., Gerard, N. P., Wyatt, R., Choe, H., Parolin, C., Ruffing, N., Borsetti, A., Cardoso, A. A., Desjardin, E., Newman, W., Gerard, C. and Sodroski, J., 1996, CD4-induced interaction of primary HIV-1 gp120 glycoproteins with the chemokine receptor CCR-5. Nature, 384, 179–183.
   PubMed Web of Science ®Google Scholar
• Zaitseva, M., Blauvelt, A., Lee, S., Lapham, C. K., Klaus-Kovtun, V., Mostowski, H., Manischewitz, J. and Golding, H., 1997, Expres-sion and function of CCR5 and CXCR4 on human Langerhans cells and macrophages: Implications for HIV primary infection. Nature Medicine, 3, 1369–1375.
   PubMed Web of Science ®Google Scholar